featured
RAW Rolling Papers Founder Buys High Times

Published
8 hours agoon

The founder of RAW Rolling Papers is the new owner of the High Times brand. Josh Kesselman and former High Times co-owner Matt Stang last week purchased the magazine, Cannabis Cups, and all associated assets in a $3.5 million all-cash transaction.
In a statement, Kesselman called the acquisition a “‘pinch yourself’ kind of moment.”
“Eighteen-year-old stoner Josh would be in complete disbelief that I get to bring back a piece of history that has played such an important part in culture and impacted so many lives, including my own. This feels like a dream. Having Matt Stang, an OG and a former owner-operator of the magazine, involved in this acquisition just makes it all come full circle. It’s surreal to be a small part of giving back to the community that helped make me.” — Kesselman in a press release
Stang said, “This incarnation of High Times is going to be bigger and better than ever.”
“As an original owner-operator, I’m energized about my partnership with Josh – we’re not just reviving High Times as a news source, we’re positioning it as a guiding light for culture and a definitive authority on all things cannabis and psychedelics,” Stang said in a statement. “At its heart, this is about reigniting the passion of longtime fans while inspiring a new generation to carry the torch forward. It’s about sharing, connection and honoring the culture that we love so dearly.”
As part of the relaunch, the new owners plan to bring back the print magazine in limited-run, collectible editions, reintroduce the Cannabis Cup event series, “with third-party judging” and “zero pay-to-play involvement,” and rebuild the digital platform to host a network of cannabis podcasts, experts, and community voices.
They expect the Cannabis Cup to return next year.
“Our goal is to rebuild the voice of authenticity that defined High Times’ legacy,” Kesselman said, “to cut through the controversy of inaccurate information, create a truly cross-generational community, and restore High Times to its rightful place as an international beacon of counterculture.”
High Times was founded in 1974 but was sold to Hightimes Holding Corp. – a group of investors led by Oreva Capital Founder Adam Levin in 2017. The following year, the company initiated a Regulation A (Reg A) public offering, allowing non-institutional investors to purchase shares directly, which aimed to generate up to $50 million to support the company’s expansion plans, including acquisitions and a potential public listing. However, by June 2019, the company had raised only $15 million and in July 2020, the U.S. Securities and Exchange Commission ordered a halt to the High Times IPO after the company missed its annual report deadline. The company announced several moves – acquiring cannabis magazine DOPE (and subsequently firing many of its employees) and planning a chain of dispensaries – but last year announced a deal to sell all of its intellectual property to Lucy Scientific Discovery Inc., a Vancouver, British Columbia, Canada-based Nasdaq-listed company with holdings and operations in a variety of psychotropic businesses.
In January, Levin pleaded guilty to conspiracy charges involving undisclosed payments to a stock analyst. According to the U.S. Department of Justice, Levin participated in a scheme to pay over $150,000 to an investment newsletter analyst who promoted Hightimes’ stock without disclosing the compensation.
Get daily cannabis business news updates. Subscribe
Have an additional perspective to share? Send us a message to let us know, and if your comment is chosen by our editors it could be featured here.
Perspective to add? Suggest a revision or submit commentary for review using the form below.
Ganjapreneur is made possible by our partners:

Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.
You may like
-
Aurora Launches 2 High-Potency Flower Products in Poland
-
Pennsylvania Lawmakers Are ‘Getting Close’ On Marijuana Legalization Deal As Budget Deadline Looms, Key Senator Says
-
Tilray Medical Receives Italy’s 1st Authorization to Distribute Medical Cannabis Flower
-
Congressional Committee Approves Federal Hemp THC Ban That Stakeholders Say Would Decimate Industry
-
Cannabis users are too dangerous to have guns, Trump admin tells SCOTUS (Newsletter: June 24, 2025)
-
Social cannabis license rules could be finalized in July
featured
Aurora Launches 2 High-Potency Flower Products in Poland

Published
20 seconds agoon
June 24, 2025
[PRESS RELEASE] – EDMONTON, Alberta, June 24, 2025 – Aurora Cannabis Inc., the Canadian-based leading global medical cannabis company, announced the launch of two proprietary cultivars in Poland, marking the highest potency medical cannabis products available in the country. Grown and manufactured in the company’s Canadian GACP and EU-GMP facilities, the premium dried medical cannabis products Farm Gas and Sourdough are crafted with precision and expertise to deliver a superior, high-THC flower.
“As a result of our cutting-edge genetic breeding program, we’re best positioned to introduce these tried-and-true proprietary cultivars into the Polish market with assurance in quality and excellence,” said Michael Simon, vice president of Commercial at Aurora Europe. “We recognize that prescribers are looking for high-quality, high-potency medical cannabis products for their patients, and we’re proud to offer superior products with proven success in the Canadian market.”
The first cultivar, available on June 30 for prescription, is Farm Gas, followed by Sourdough, which will be available in early August. These specialty dried flowers are hang-dried, hand-finished and have unique and favorable properties including:
- Farm Gas | 27% THC, <1% CBD, bred from Sour Diesel and GMO genetics. This cultivar has a terpene profile of limonene, caryophyllene, nerolidol, and an aroma profile that features notes of kerosene, diesel and gas with a slight chem taste, followed by a slightly sweet finish with fruit sherbet undertones.
- Sourdough | 29% THC, <1% CBD, bred from Cake and Diesel genetics. This cultivar has a terpene profile of limonene, caryophyllene, myrcene, and an aroma profile that carries sour, cake and gasoline notes.
Aurora remains steadfast in its international leadership, leveraging the company’s unrivaled focus on science and innovation to fuel global advancements. With extensive knowledge of Europe’s intricate regulatory landscape and proven expertise in cultivation, Aurora stands as the trusted leader in advancing the Polish medical cannabis market.

Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.
featured
Pennsylvania Lawmakers Are ‘Getting Close’ On Marijuana Legalization Deal As Budget Deadline Looms, Key Senator Says

Published
1 hour agoon
June 24, 2025
A key Pennsylvania senator says he’s working with bipartisan and bicameral lawmakers to develop a passable marijuana legalization bill as the legislature stares down a quickly approaching budget deadline—telling supporters that “we’re getting close” and they shouldn’t “ease up” on the fight.
“It is time to end the prohibition on adult-use cannabis in the Commonwealth of Pennsylvania,” Sen. Shariff Street (D) said during a Cannabis Day at the Capitol event on Monday. “We’re going to make sure that we do this in an equitable way.”
“There are some basic things that we know we need to have done,” he said. “We need to make sure when we pass a recreational adult-use bill that we seal and expunge the records of all those people who’ve been who’ve had cannabis convictions in the past.”
“We need to make sure that we pass a bill that creates opportunities for all folks. That means small farmers and small business people. And we need to make sure we have a diversity of folks involved in the growing, processing and also in the dispensary part of the business,” Street said. “We need to make sure that we have a completely diverse supply chain.”
“Look, Black and brown communities were disproportionately affected by the war on cannabis. We need to make sure that they equally benefit in the cannabis legalization market, and that’s why we need to make sure we have social equity licenses. We need to make sure that we have social equity grants. We need to make sure that the communities that were closest to the pain are closest to the profits as well. We need to get this done, because it makes no sense that our revenue goes across the lines.”
“Almost all the states around us have already legalized adult-use cannabis, and we know, even though it’s not federally lawful, people are driving right across that border and consuming legal, adult-use cannabis,” he said. “That revenue is going to all of our border states, and it’s not going into the Commonwealth of Pennsylvania.”
“I want you to know we’re getting close. This is not the time to ease up. This is not the time to back off,” the senator said. “We are closer now to ever passing an adult-use cannabis bill and getting it on the governor’s desk.”
Street thanked his bipartisan colleagues in the House—including Reps. Emily Kinkead (D), Abby Major (R) and Amen Brown (D), who have championed their own legalization proposals—for working with the Senate “in a collaborative way.”
“We have a good core group of us who’ve been working to move this bill—to move this concept forward—and I think we’re gonna get it done,” he said. “We need your voices to stay engaged. We need to stay involved.”
The senator also stressed the need to allow medical cannabis patients to grow their own medicine for personal use, saying that if it’s “a plant that comes from the earth, and if people want to grow it in order to take care of their own needs, that should be included as well” in a reform plan.
“So look, we’re moving forward,” he said. “But Pennsylvania law has not caught up with the realities of our situation… We need to end the prohibition of cannabis, adult-use cannabis, in Pennsylvania. Now we need to do it in a fair and equitable way.”
Kinkead, also speaking at the Monday rally, said that while she and other House Democrats recently passed a bill to legalize cannabis sales through a system of state-run stores, “I disagree with that model, because I think that a state that for generations has criminalized a substance should not be the primary beneficiary of that substance when it’s legalized—it should be the communities that we have been criminalized.”
“We cannot legalize marijuana without considering the impacts that we have had on communities by the over criminalization of marijuana,” she said, “and that has to be the first and foremost thought when we talk about adult-use marijuana, we have to be putting investments back into the communities that have been most negatively impacted by the failed war on drugs.”
Rep. Chris Rabb (D-PA) similarly said that “the bill that we passed out of the House will not be the bill that comes before us when we finally vote to legalize adult-use cannabis.
“What we will ultimately vote on will look very different than what we’ve considered thus far,” he said. “And there are a lot of great minds who’ve come together on a number of pieces of legislation.”
“If we try to pass a bill that’s about generating tax revenue for other purposes, we’ve lost. So folks who are talking about, ‘this will be a great revenue generated to X, Y and Z’—that’s not how we should lead on this subject. It should be around criminal legal reform. It should be around racial justice. It should be around community safety, public health, social impact—not about creating more money for politicians to support various projects of theirs back home or what have you. If you’re putting an egregious tax on weed, who’s going to buy it?”
Other lawmakers continue to emphasize the revenue generating potential of legalization, however.
House Appropriations Committee Chair Jordan Harris (D) also weighed in on cannabis policy issues in an interview with WHTM that aired on Sunday, saying that the “states around us have already legalized adult-use cannabis.”
“This is another opportunity for us to generate revenue. We’re leaving money on the table, but not only are we leaving money on the table if you talk to our friends in New York, if you talk to our friends in New Jersey, what they’ll tell you, honestly, is ‘Thank you. Thank you,’” he said. “Tell the Pennsylvanians who flood to New York and flood to New Jersey and spend their money in their [legalized marijuana] market. Those are taxpayer dollars that we should be having.”
Meanwhile, Senate Majority Leader Joe Pittman (R) recently said marijuana legalization will not be included in the 2026 budget as lawmakers approach a deadline he expects they will miss. But Gov. Josh Shapiro (D) is still holding out hope that negotiators can “get it done.”
With the budget due by a constitutionally mandated deadline of June 30, legislators appear to be at an impasse on certain key issues, including the governor’s request to legalize adult-use cannabis via the legislation. Pittman said he doesn’t see a path forward for the reform on that schedule, however.
Shapiro, on the other hand, hasn’t quite thrown in the towel, saying at a press briefing last week that “we all understand we have to compromise” on a number of issues to reach a budget agreement.
“We also, I think, all understand the set of issues we have to work through—and we’re going to continue to work through them,” he said. “We’re each going to have to give a little bit. We’re going to make progress. We’re going to get it done.”
Pittman, for his part, criticized House lawmakers for passing a marijuana legalization bill that would have involved state-run shops. The legislation was quickly rejected by a Senate committee.
Following that defeat, the governor said he still remained “hopeful” that lawmakers could deliver a reform bill to his desk by a budget deadline at the end of this month—and he urged the GOP-controlled Senate to “put their ideas on the table.”
“We’ve had really good, honest dialogue about it,” the governor, who separately criticized the Senate for abruptly derailing the House marijuana legalization bill, said.
“Look, I think this is an issue of competitiveness,” he said. “Every state around us, with the exception of West Virginia, has gotten it done. You go visit some of these dispensaries along our border—in this case with Maryland, [that] is probably the closest one here. Sixty percent of the people walking into those dispensaries are from the Commonwealth of Pennsylvania.”
Whether Pennsylvania legislators will advance legalization this session remains to be seen. But two Democratic lawmakers—Street and Rep. Rick Krajewski (D)—recently said they’re aiming to reach a compromise and pass reform legislation before the budget deadline.
Also, last month Sen. Marty Flynn (D) announced his intent to file a new bill to legalize marijuana in the state, calling on colleagues to join him on the measure.
While the House legislation Krajewski sponsored alongside Rep. Dan Frankel (D) was rejected in a Senate committee following its expedited passage through the House along party lines, Street said he’s “cautiously optimistic we’re going to be able to revive the bill and amend it and move forward with a work product that allows us to get a bill on the governor’s desk and realize revenue.”
That said, Sen. Dan Laughlin (R), who has sponsored legalization legislation with Street, recently seemed to suggest that lawmakers should pump the brakes on the push to enact the policy change amid resistance to reform within his caucus and instead pass a bill to create a new regulatory body that can begin overseeing medical cannabis and hemp while preparing to eventually handle the adult-use market as well.
“I remain committed to crafting a cannabis bill that can pass the Senate and be signed into law to benefit all Pennsylvanians,” Laughlin said. “That starts with honest dialogue from everyone involved, including House leadership and the governor, to develop a realistic approach–not political theater.”
Following the Senate committee vote, lawmakers from both chambers who support legalization have been trading criticisms about each other’s roles in the stalled push to end prohibition.
Krajewski, for example, recently wrote in a Marijuana Moment op-ed that Senate Republicans who killed his House-passed cannabis legalization bill are “stuck in their prohibitionist views of the past” and are “out of touch with the will of our Commonwealth.”
Prior to that vote, Pennsylvania’s Republican attorney general said that while he doesn’t currently support the House-passed marijuana legalization bill, he’s open to changing his mind about the policy change after continuing to review the details.
For what it’s worth, a recent poll found that Pennsylvania voters say they favor a model where cannabis is sold by licensed private businesses, rather than through a system of state-run stores.
The governor has repeatedly called for adult-use marijuana legalization. However, he hasn’t endorsed the specific idea of having a state-controlled model.
GOP lawmaker Major—who is sponsoring another forthcoming legalization bill that envisions a traditional private sales model alongside Democrat Kinkead—said during the House floor debate on HB 1200 that she stands opposed to the competing bill, emphasizing that she disagrees with the state-run stores proposal.
While Democrats control the House and governor’s office, they will still need to reach a deal with the GOP-controlled Senate to effectuate change. And in addition to the conflicting perspectives among pro-legalization legislators, another potential barrier to reform is exactly that political dynamic.
Regardless of which direction Pennsylvania lawmakers do—or don’t—go on marijuana legalization this session, a survey released in April shows a majority of adults in the state support the reform—and opposition to the policy change has fallen by nearly 50 percent over the last decade.
Kinkead has made the case in another recent interview that legalizing cannabis in Pennsylvania will help the state mitigate public health and safety concerns associated with the illicit market, including the fact that unregulated products can be laced with fentanyl.
The lawmaker previously introduced a separate bipartisan marijuana legalization bill, alongside 15 other cosponsors, last September. It did not advance, however.
Meanwhile, Laughlin recently called for the creation of a state “legacy” fund, using tax revenue from adult-use marijuana sales and gaming to make long-term investments in the Commonwealth’s economy.
The senator argued that, beyond using any resulting tax revenue to fund day-to-day projects and public services, the state should earmark a portion of those tax dollars for a fund to “provide a sustainable source of prosperity that lasts for generations.”
Another GOP Pennsylvania senator, Sen. Gene Yaw (R), is backing the push to legalize marijuana in the commonwealth, pointing out that, historically, prohibition “has not turned out well,” noting the country’s experience with alcohol criminalization.
Pennsylvania House Speaker Joanna McClinton (D) recently said that Democrats are ready to pass a marijuana legalization bill this session, but that the party “will need Republican support” to get the job done—adding that it will be a “heavy lift.”
Polls have shown bipartisan support for legalization among voters, but the reform has consistently stalled in the legislature, owing in large part to GOP opposition. But not all Republican members are against the policy change—and one recently said she felt her party should seize the “opportunity to snatch” the issue from Democrats.
Separately in March, the Pennsylvania House approved a bill sponsored by Frankel that’s meant to strengthen safety standards and oversight of the state’s medical marijuana program as lawmakers work to advance adult-use legalization.
While Pennsylvania’s medical cannabis program was enacted nearly a decade ago, lawmakers say the measure, which now heads to the Senate, is necessary to improve testing compliance, product audits and lab inspections, among other aspects of the industry.
Meanwhile, Pennsylvania Democratic lawmakers recently introduced a bill that would allow farmers and other small agriculture operators to sell marijuana they cultivate to existing growers and and processors if the state moves to legalize adult-use cannabis.
Separately, an independent Pennsylvania agency is projecting more tax dollars to be generated from adult-use marijuana sales compared to what the governor’s office has estimated, although it expects significantly less overall revenue from cannabis legalization due to differing views on licensing fees.
Pennsylvania officials have also launched a new survey that invites legal marijuana businesses across the country to provide information about their operations to help the state better understand the cannabis industry as lawmakers consider enacting adult-use legalization this session.
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
Also, in a video interview released in March, the governor emphasized that the state is “losing out” to others that have already enacted adult-use legalization, while maintaining a policy that’s enriched the illicit market.
“I think it’s an issue of freedom and liberty. I mean, if folks want to smoke, they should be able to do so in a safe and legal way,” he said. “We should shut down the black market—and, by the way, every state around us is doing it. Pennsylvanians are driving to those other states and paying taxes in those other states.”
The state’s agriculture secretary separately told lawmakers that he’s fully confident that his department is in a “really good” position to oversee an adult-use marijuana program if lawmakers act.
Meanwhile, in February, top Pennsylvania police and health officials told lawmakers they are prepared to implement marijuana legalization if the legislature moves forward with the reform—and that they stand ready to work together as the details of legislation to achieve it are crafted.
Amid the growing calls for marijuana legalization in Pennsylvania, a GOP state senator said prohibition has been a “disaster,” and a regulated sales model for cannabis—similar to how alcohol and tobacco are handled—could serve as an effective alternative.
A Republican Pennsylvania senator also recently defended the push to legalize and regulate marijuana, calling it “the most conservative stance” on the issue.
Texas GOP Governor ‘Wants To Legalize Recreational Marijuana,’ Lieutenant Governor Claims

Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.
featured
Tilray Medical Receives Italy’s 1st Authorization to Distribute Medical Cannabis Flower

Published
2 hours agoon
June 24, 2025
[PRESS RELEASE] – SAVONA, Italy, June 24, 2025 – Tilray Medical, a division of Tilray Brands Inc. and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and health care practitioners to make informed individualized health decisions, announced a significant milestone in its European expansion with the introduction of three new medical cannabis flower varieties in Italy.
Through its wholly-owned subsidiary, FL Group, Tilray has become the first company in Italy to receive official authorization from the Ministero della Salute (Italian Ministry of Health) to import and distribute proprietary Tilray Medical-branded medical cannabis flower for therapeutic use.
Beginning this month, the following Tilray Medical products are approved for therapeutic use in Italy and available for distribution through pharmacies across Italy:
- Tilray THC 25%
- Tilray THC 18%
- Tilray THC 9% / CBD 9%
“This milestone underscores the vital role of medical cannabis as a therapeutic medicine for patients in need, supporting their health and well-being,” Denise Faltischek, chief strategy officer and head of International at Tilray Brands, said.
“We are proud to expand our medical cannabis portfolio in Italy with the introduction of our Tilray Medical high-quality, EU-GMP certified medical cannabis products that uphold the highest standards in patient care,” Faltischek said. “We extend our gratitude to the Ministero della Salute for their trust in Tilray Medical and for providing the necessary regulatory framework to ensure access to safe, consistent and reliable cannabinoid-based therapies. Together, we are advancing health care and patient wellness through innovation and collaboration.”
Tilray continues to lead the European medical cannabis market with operations in Germany, Italy, Portugal, Poland and the United Kingdom, offering a broad portfolio of EU-GMP certified medical cannabis products.

Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.

Aurora Launches 2 High-Potency Flower Products in Poland

Pennsylvania Lawmakers Are ‘Getting Close’ On Marijuana Legalization Deal As Budget Deadline Looms, Key Senator Says

Tilray Medical Receives Italy’s 1st Authorization to Distribute Medical Cannabis Flower

Congressional Committee Approves Federal Hemp THC Ban That Stakeholders Say Would Decimate Industry

Cannabis users are too dangerous to have guns, Trump admin tells SCOTUS (Newsletter: June 24, 2025)

Social cannabis license rules could be finalized in July

Cannabis Law Now Podcast – Cannabis in the Show Me State: An Interview with BeLeaf Medical’s Mitch Meyers | Husch Blackwell LLP

Alabama Expected to Issue Medical Cannabis Dispensary Licenses Soon

Mississippi AG Says Intoxicating Hemp Products Are ‘Prohibited’ Under State Law

RAW Rolling Papers Founder Buys High Times

Delta In a Minute 6-19

MSO Nar Cannabis opens NJ dispensary near Philadelphia (photos)

7 In 10 US Voters Support Federal Marijuana Reform, And Nearly Half Would View Trump More Favorably If He Took Action, Poll Shows

Michigan Marijuana Shop’s Bigfoot Statue Is Creating Controversy, With Critics Saying It Appeals To Kids

How does high-potency cannabis affect our brains?

New Poll Shows Most Utah Voters Support Marijuana Legalization, But Top GOP Lawmakers Reiterate Opposition To Reform

Texas becomes the 40th medical cannabis state!

Texas GOP Governor ‘Wants To Legalize Recreational Marijuana,’ Lieutenant Governor Claims

DEA Judge Sides With Agency On Proposal To Ban Two Psychedelics Despite Challenge From Scientific Researchers

Texas Governor Vetoes Ban on Hemp Products, Calls For Special Session to Regulate THC

5-6 Men Under Influence Of ‘Marijuana’ Assault, Molest Woman In Broad Daylight In Bengaluru

What is Leafly’s queer staff smoking this Pride?

Colorado Gov. Announces Pardons for Psychedelics Possession

Video: Johnny Bananas partners with Cincinnati’s King City Gardens for cannabis gummies

Alert: Department of Cannabis Control updates data dashboards with full data for 2023

Connecticut Appoints The US’s First Cannabis Ombudsperson – Yes there is a pun in there and I’m Sure Erin Kirk Is Going To Hear It More Than Once!

5 best CBD creams of 2024 by Leafly

Free delta-9 gummies from Bay Smokes

New Study Analyzes the Effects of THCV, CBD on Weight Loss

EU initiative begins bid to open access to psychedelic therapies

Mississippi city official pleads guilty to selling fake CBD products

May 2024 Leafly HighLight: Pink Runtz strain

Curaleaf Start Process Of Getting Their Claws Into The UK’s National Health System – With Former MP (Resigned Today 30/5/24) As The Front Man

5 best autoflower seed banks of 2024 by Leafly

Horn Lake denies cannabis dispensary request to allow sale of drug paraphernalia and Sunday sales | News

Discover New York’s dankest cannabis brands [September 2024]

Press Release: CANNRA Calls for Farm Bill to Clarify Existing State Authority to Regulate Hemp Products

Nevada CCB to Accept Applications for Cannabis Establishments in White Pine County – “Only one cultivation and one production license will be awarded in White Pine County”

Local medical cannabis dispensary reacts to MSDH pulling Rapid Analytics License – WLBT

6 best CBD gummies of 2024 by Leafly

5 best THC drinks of 2024 by Leafly

The Daily Hit: October 2, 2024

5 best delta-9 THC gummies of 2024 by Leafly

People In This State Googled ‘Medical Marijuana’ The Most, Study Shows

Weekly Update: Monday, May 13, 2024 including, New Guide for Renewals & May Board meeting application deadline

Thailand: Pro-cannabis advocates rally ahead of the government’s plan to recriminalize the plant

PRESS RELEASE : Justice Department Submits Proposed Regulation to Reschedule Marijuana

Press Release: May 9, STIIIZY and Healing Urban Barrios hosted an Expungement Clinic & Second Chance Resource Fair
Trending
-
California Cannabis Updates1 year ago
Alert: Department of Cannabis Control updates data dashboards with full data for 2023
-
Breaking News1 year ago
Connecticut Appoints The US’s First Cannabis Ombudsperson – Yes there is a pun in there and I’m Sure Erin Kirk Is Going To Hear It More Than Once!
-
best list11 months ago
5 best CBD creams of 2024 by Leafly
-
Bay Smokes12 months ago
Free delta-9 gummies from Bay Smokes
-
cbd1 year ago
New Study Analyzes the Effects of THCV, CBD on Weight Loss
-
Business9 months ago
EU initiative begins bid to open access to psychedelic therapies
-
Mississippi Cannabis News1 year ago
Mississippi city official pleads guilty to selling fake CBD products
-
California1 year ago
May 2024 Leafly HighLight: Pink Runtz strain